Provider Prices in the Commercial Sector: Reaching a Common Understanding
Why It Matters
Redirecting reform toward hospital pricing and data transparency targets the biggest cost driver, offering a more effective lever to slow commercial health‑spending growth.
Key Takeaways
- •Hospital services account for roughly 31% of U.S. health spending.
- •Private insurance spending grew nearly 9% in 2024, outpacing other sectors.
- •Policy focus should shift toward hospital price reforms, not just drugs.
- •Transparency and employer access to claims data can drive better negotiations.
- •Price level and growth differ; high prices don’t guarantee rapid growth.
Summary
The virtual event, hosted by Health Affairs and funded by Arnold Ventures, examined how provider prices—especially hospital charges—drive commercial health‑spending growth.
Data presented showed hospitals consume about 31% of total U.S. health expenditures, physician services 21%, and prescription drugs only 9%. Private‑insurance spending rose nearly 9% in 2024, outpacing Medicare and Medicaid, while hospital‑care costs grew faster than other segments.
Senator Roger Marshall’s policy director Max Seltzer warned that the focus on drug pricing overlooks the larger hospital share. Panelists Melinda Buntton, Mike Cheru and Irene Papa‑Nicholas highlighted semantic debates over price versus quantity and noted that high price levels do not always correlate with rapid price growth.
The discussion underscores a policy shift toward hospital‑price transparency, employer access to claims data, and more aggressive network negotiations, which could curb overall commercial spending growth.
Comments
Want to join the conversation?
Loading comments...